The global healthcare industry is increasingly focusing on rare disease management and advanced hematology treatments, creating strong growth opportunities for the acquired hemophilia treatment market. Acquired hemophilia is a rare autoimmune bleeding disorder caused by the development of autoantibodies against clotting factors, particularly factor VIII. The condition can lead to severe...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek